DK1678130T3 - Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H chromomen-6-yl derivatives and drugs containing these compounds - Google Patents

Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H chromomen-6-yl derivatives and drugs containing these compounds

Info

Publication number
DK1678130T3
DK1678130T3 DK04817204T DK04817204T DK1678130T3 DK 1678130 T3 DK1678130 T3 DK 1678130T3 DK 04817204 T DK04817204 T DK 04817204T DK 04817204 T DK04817204 T DK 04817204T DK 1678130 T3 DK1678130 T3 DK 1678130T3
Authority
DK
Denmark
Prior art keywords
chromomen
amidomethyl
sulphonylamino
dihydro
hydroxy
Prior art date
Application number
DK04817204T
Other languages
Danish (da)
Inventor
David Sykes
Brian Moloney
Lester Marrison
Dieter Ziegler
Michael Mlinaric
Christiane Boecker
Reinhard Brueckner
Michael Weske
Klaus Witte
Yvan Fischer
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK1678130T3 publication Critical patent/DK1678130T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04817204T 2003-10-17 2004-10-14 Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H chromomen-6-yl derivatives and drugs containing these compounds DK1678130T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10348298A DE10348298A1 (en) 2003-10-17 2003-10-17 Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation, and medicaments containing these compounds
PCT/EP2004/052539 WO2005037780A2 (en) 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds

Publications (1)

Publication Number Publication Date
DK1678130T3 true DK1678130T3 (en) 2008-12-01

Family

ID=34442032

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04817204T DK1678130T3 (en) 2003-10-17 2004-10-14 Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H chromomen-6-yl derivatives and drugs containing these compounds

Country Status (25)

Country Link
EP (1) EP1678130B1 (en)
JP (1) JP4791968B2 (en)
KR (1) KR20060129170A (en)
CN (1) CN100532375C (en)
AR (1) AR046106A1 (en)
AT (1) ATE405547T1 (en)
AU (1) AU2004281195B2 (en)
BR (1) BRPI0415523A (en)
CA (1) CA2542813C (en)
DE (3) DE10348298A1 (en)
DK (1) DK1678130T3 (en)
ES (1) ES2313126T3 (en)
HK (1) HK1096960A1 (en)
HR (1) HRP20080602T3 (en)
IL (1) IL174950A (en)
MX (1) MXPA06003958A (en)
NO (1) NO20062202L (en)
PL (1) PL1678130T3 (en)
PT (1) PT1678130E (en)
RU (1) RU2355685C2 (en)
SI (1) SI1678130T1 (en)
TW (1) TWI321564B (en)
UA (1) UA82907C2 (en)
WO (1) WO2005037780A2 (en)
ZA (1) ZA200602788B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871758B1 (en) * 2005-04-12 2010-08-25 Abbott Products GmbH Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
JP4943429B2 (en) * 2005-07-22 2012-05-30 メルク・シャープ・エンド・ドーム・コーポレイション Potassium channel inhibitor
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
NO3175985T3 (en) 2011-07-01 2018-04-28
JP2015504923A (en) 2012-01-27 2015-02-16 ギリアード サイエンシーズ， インコーポレイテッド Combination therapy using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ282172B6 (en) * 1992-11-30 1997-05-14 Smithkline Beecham Plc Benzopyran analogs process for preparing such compounds, pharmaceutical composition containing such compounds and the use thereof
DE19546736A1 (en) * 1995-12-14 1997-06-19 Hoechst Ag Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations
WO2000012077A1 (en) * 1998-09-01 2000-03-09 Bristol-Myers Squibb Company Potassium channel inhibitors and method
WO2000058300A1 (en) * 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Chroman derivatives
JP2000336085A (en) * 1999-03-25 2000-12-05 Nissan Chem Ind Ltd Chroman derivative
AU781365B2 (en) * 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors

Also Published As

Publication number Publication date
CA2542813A1 (en) 2005-04-28
WO2005037780A2 (en) 2005-04-28
TW200523259A (en) 2005-07-16
HRP20080602T3 (en) 2008-12-31
RU2355685C2 (en) 2009-05-20
PT1678130E (en) 2008-10-08
CN100532375C (en) 2009-08-26
DE502004007916D1 (en) 2008-10-02
DE112004001659D2 (en) 2006-08-10
NO20062202L (en) 2006-07-03
CN1894233A (en) 2007-01-10
CA2542813C (en) 2011-08-30
EP1678130B1 (en) 2008-08-20
MXPA06003958A (en) 2006-07-05
ES2313126T3 (en) 2009-03-01
IL174950A (en) 2010-06-30
EP1678130A2 (en) 2006-07-12
IL174950A0 (en) 2006-08-20
AU2004281195A2 (en) 2005-04-28
PL1678130T3 (en) 2009-01-30
JP4791968B2 (en) 2011-10-12
DE10348298A1 (en) 2005-05-19
BRPI0415523A (en) 2006-12-26
JP2007516235A (en) 2007-06-21
ZA200602788B (en) 2008-01-30
HK1096960A1 (en) 2007-06-15
SI1678130T1 (en) 2008-12-31
ATE405547T1 (en) 2008-09-15
UA82907C2 (en) 2008-05-26
KR20060129170A (en) 2006-12-15
TWI321564B (en) 2010-03-11
AU2004281195A1 (en) 2005-04-28
AR046106A1 (en) 2005-11-23
AU2004281195B2 (en) 2010-12-16
RU2006116629A (en) 2007-11-27
WO2005037780A3 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
NO20053201D0 (en) New heterocyclic fluoroglucose derivatives, drugs containing these compounds and their use.
LTC1633724I2 (en) Phthalazinone derivatives
NO20043733L (en) Aryl-5-thio-Β-D-glucopyranoside derivatives and drugs for diabetes containing the same
NO20040512L (en) Downhole calibration system for directional sensors.
CY2013029I1 (en) NEW INSULIN DERIVATIVES
DK1615646T4 (en) PHARMACEUTICAL FORMULATIONS CONTAINING METHYLNALTREXONE
DK1523488T3 (en) Novel Thiophenglycoside Derivatives, Methods for their Preparation, Drugs Containing These Compounds and Their Use
DK1572707T3 (en) New Aromatic Fluorine Glycoside Derivatives, Drugs Containing These Compounds, and Uses thereof
IS7659A (en) COX-2 inhibiting pyridine derivatives
DK1730131T3 (en) Glucopyranosyl-substituted benzene derivatives, drug containing these compounds, their use and methods for their preparation
ATE340782T1 (en) PIPERIDINEBENZENESULFONAMIDE DERIVATIVES
NL1030486A1 (en) Dibenzylamine compounds and derivatives.
NO20054136D0 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
DK1385825T3 (en) Substituted 2-pyridine cyclohexane-1,4-diamine derivatives
IS8364A (en) N-thiazol-2-yl-benzamide derivatives
IL174950A0 (en) Amidomethyl-subsituted 2-(4-sulfonilamino)-3-hydroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds
DK2275439T3 (en) Hitherto unknown insulin derivatives
DE602004007387D1 (en) 5-SUBSTITUTED CHINAZOLINONE DERIVATIVES
ATE449064T1 (en) AMIDOACETONITRIL DERIVATIVES
IS8235A (en) 2-aminobenzoyl derivatives
NO20053805D0 (en) Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof
NO20054141D0 (en) Substituted 2- (diaza-bicycloalkyl) pyrimidone derivatives
DE602004009273D1 (en) phase detector
ITMI20030485A1 (en) PERFECTLY OFFSET DETECTOR, PARTICULARLY
UY28661A1 (en) CHROMAN DERIVATIVES